April 15, 2008 - Physician scientists at the Texas Heart Institute (THI) at St. Luke's Episcopal Hospital have begun the world's first clinical trial to treat heart attack patients with a special type of stem cell to promote better healing and to prevent congestive heart failure, which many patients develop following a heart attack.

April 15, 2008 - Researchers at the University of North Carolina at Chapel Hill's School of Medicine have shown some heart cells in response to one signal will act, while others lie in wait, countering the belief that precursor cells all respond to the same cue before turning into the muscle tissue of this vital organ.

April 15, 2008 – The American College of Cardiology, American College of Emergency Physicians and the Duke University School of Medicine are hosting a two-day program on emergency cardiovascular care that will examine strategies to enhance STEMI systems for reperfusion, May 30-31 at the Fairmont Hotel in Washington D.C.

April 14, 2008 - Contrast-enhanced MR imaging is significantly superior to 16 slice multidetector CT in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study conducted by researchers at Ospedale San Giovanni in Bellinzona, Switzerland.

April 14, 2008 - Boston Scientific Corp. reported that the Japanese Ministry of Health, Labor and Welfare (MHLW) approved ACUITY Steerable left ventricular lead for use with cardiac resynchronization therapy (CRT) devices, which treat heart failure.

The Company, which also received reimbursement approval for the lead from the National Health Insurance System, plans to launch the product immediately in Japan.

April 14, 2008 - MAQUET Cardiovascular launched HEARTSTRING III Proximal Seal System for coronary artery bypass surgery procedures, a proximal seal technology that allows surgeons to perform coronary artery bypass grafts without the use of a partial occlusion clamp during beating heart surgery.

April 14, 2008 - ESTECH will showcase its new CG LiV Kits, designed to enable mitral and aortic valve procedures, at the American Association for Thoracic Surgery 88th Annual Meeting in San Diego.

April 14 - Doctors implanted the ATS 3f Aortic Bioprosthesis, marking the first North American commercial implant after ATS Medical Inc. received Canadian regulatory approval for the device at the end of December, 2007.

The first implant was performed by Benoit de Varennes, M.D., MSc, FRSC, chairman, Division of Cardiac Surgery at McGill University in Montreal, Canada. The patient was a 76-year-old man with aortic valve stenosis. The valve replacement was successful and the patient has been discharged from the hospital in good condition.

MAQUET Cardiovascular offers the HEARTSTRING III Proximal Seal System for coronary artery bypass surgery procedures, a proximal seal technology that allows surgeons to perform coronary artery bypass grafts without the use of a partial occlusion clamp during beating heart surgery.

April 11, 2008 - Philips will acquire all outstanding shares in Shenzhen Goldway Industrial Inc. (Goldway), making Goldway part of the patient monitoring business within Philips Healthcare, as part of its strategy to strengthen its position in China and increase its presence in emerging markets.

Goldway offers patient-monitoring solutions that range from basic standalone to more fully-equipped monitors, including products that have been FDA approved in the U.S. or carry the CE certification in Europe.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now